CRC Longevity has been shortlisted for Stage 2!

CRC Longevity has been shortlisted for Stage 2!

We’re so excited to announce that CRC Longevity has been shortlisted for stage 2 submissions as part of the Round 22 CRC funding!

We are absolutely thrilled that our journey to collaborate and investigate the issues impacting the longevity of all Australians continues.

There were 14 bids in this competitive and tough round, and we are one of only five bids to be shortlisted which is a testament to both the strength of our bid, the hard work of our industry partners and researchers, and the profound impact CRC Longevity will have on all Australians.

Here is a short video message from our CRC Leadership team about our shortlisting to Stage 2 submissions:

Professor Laurie Buys: Research Director and Bid Lead
Kathryn Greiner AO: Chair of the Board
David Barbagallo: Interim CEO
Dr Nicole Walker: Bid Manager

Stage 2 opens on Tuesday and closes on 18 January 2021, so we will be working hard over the next few weeks to finalise our Stage 2 submission.

Congratulations to everyone involved. If you have any questions about CRC Longevity, or would like to get involved, get in touch with Laurie Buys.

Leave a Reply

Your email address will not be published. Required fields are marked *